Abstract
The discriminative stimulus effects of benzodiazepines often have been indistinguishable from those of barbiturates or other sedative/anxiolytics. However, baboons and rats trained to discriminate lorazepam did not reliably generalize to pentobarbital in previous studies, although animals comparably trained to discriminate pentobarbital reliably generalized to lorazepam. The present study investigated the generalization profile for a variety of anxiolytic, sedative and other drugs in baboons trained to discriminate oral lorazepam (1.8 mg/kg). Triazolam, alprazolam, diazepam, midazolam, bromazepam, temazepam and nordiazepam occasioned >80% of total responses on the lorazepam-paired lever, in that order of potency, 60 min after oral dosing; chlordiazepoxide did so in three of five baboons. However, barbiturates (amobarbital, hexobarbital, methohexital, pentobarbital, phenobarbital, secobarbital) and methyprylon occasioned lorazepam-appropriate responding in only one or two baboons. Testing barbiturates at different pretreatment times (amobarbital, hexobarbital, pentobarbital or secobarbital) or by an i.m. route of administration (methohexital, pentobarbital) did not produce an increase in generalization. Neither other classic sedatives/anxiolytics (chloral hydrate, clomethiazole, ethanol, methaqualone, meprobamate, triclofos), nor anticonvulsants (phenytoin, valproic acid), nor drugs from other pharmacological classes shared discriminative-stimulus effects with lorazepam. These results, together with those from previous studies in which lorazepam or another benzodiazepine served as the training stimulus, indicate that lorazepam training results in a more selective generalization profile with respect to sedative/anxiolytic drugs than does training with other benzodiazepines.
Footnotes
-
Send reprint requests to: Nancy A. Ator, Ph.D., Behavioral Biology Research Center, 5510 Nathan Shock Drive, Ste. 3000, Johns Hopkins Bayview Campus, Baltimore, MD 21224-6823.
-
↵1 About a third of this work was supported by grant DA01147 and the rest was supported by grant DA04133 from the National Institute on Drug Abuse. A portion of these findings was reviewed inAtor and Griffiths, 1989a; preliminary data for the drugs tested in conjunction with CPDD were presented by Brady et al.(1990).
- Abbreviations:
- Bz
- Benzodiazepine
- Δ9-THC
- Δ9-tetrahydrocannabinol
- EtOH
- ethanol
- GABA
- γ-aminobutyric acid
- ND
- no drug
- PCP
- phencyclidine HCl
- p.o.
- per os.
- Received June 3, 1996.
- Accepted May 27, 1997.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|